113 related articles for article (PubMed ID: 2988834)
1. Lysis of varicella zoster virus infected cells by lymphocytes from normal humans and immunosuppressed pediatric leukaemic patients.
Bowden RA; Levin MJ; Giller RH; Tubergen DG; Hayward AR
Clin Exp Immunol; 1985 May; 60(2):387-95. PubMed ID: 2988834
[TBL] [Abstract][Full Text] [Related]
2. Varicella-zoster virus-specific HLA-restricted cytotoxicity of normal immune adult lymphocytes after in vitro stimulation.
Cooper EC; Vujcic LK; Quinnan GV
J Infect Dis; 1988 Oct; 158(4):780-8. PubMed ID: 2844916
[TBL] [Abstract][Full Text] [Related]
3. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
Diaz PS; Smith S; Hunter E; Arvin AM
J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
[TBL] [Abstract][Full Text] [Related]
4. Phenotype, cytotoxic, and helper functions of T cells from varicella zoster virus stimulated cultures of human lymphocytes.
Hayward A; Giller R; Levin M
Viral Immunol; 1989; 2(3):175-84. PubMed ID: 2483504
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte responses to varicella zoster virus in the elderly.
Hayward AR; Herberger M
J Clin Immunol; 1987 Mar; 7(2):174-8. PubMed ID: 3033012
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus-specific cytotoxic T lymphocytes (Tc): detection and frequency analysis of HLA class I-restricted Tc in human peripheral blood.
Hickling JK; Borysiewicz LK; Sissons JG
J Virol; 1987 Nov; 61(11):3463-9. PubMed ID: 2822954
[TBL] [Abstract][Full Text] [Related]
7. Processing and presentation of cell-associated varicella-zoster virus antigens by human monocytes.
Pontesilli O; Carotenuto P; Levin MJ; Suez D; Hayward AR
Clin Exp Immunol; 1987 Oct; 70(1):127-35. PubMed ID: 2826056
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic activity against varicella-zoster virus-infected target cells after marrow transplantation.
Ljungman P; Bowden RA; Meyers JD
J Clin Lab Immunol; 1990 Jan; 31(1):17-21. PubMed ID: 1966979
[TBL] [Abstract][Full Text] [Related]
9. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells.
Tilden AB; Cauda R; Grossi CE; Balch CM; Lakeman AD; Whitley RJ
J Immunol; 1986 Jun; 136(11):4243-8. PubMed ID: 3009620
[TBL] [Abstract][Full Text] [Related]
10. Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype.
Arvin AM; Sharp M; Smith S; Koropchak CM; Diaz PS; Kinchington P; Ruyechan W; Hay J
J Immunol; 1991 Jan; 146(1):257-64. PubMed ID: 1670603
[TBL] [Abstract][Full Text] [Related]
11. Specific lysis of varicella zoster virus-infected B lymphoblasts by human T cells.
Hayward AR; Pontesilli O; Herberger M; Laszlo M; Levin M
J Virol; 1986 Apr; 58(1):179-84. PubMed ID: 3005647
[TBL] [Abstract][Full Text] [Related]
12. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
[TBL] [Abstract][Full Text] [Related]
13. Human ocular-derived virus-specific CD4+ T cells control varicella zoster virus replication in human retinal pigment epithelial cells.
Milikan JC; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):743-51. PubMed ID: 18936136
[TBL] [Abstract][Full Text] [Related]
14. Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine.
Hayward A; Villanueba E; Cosyns M; Levin M
J Infect Dis; 1992 Aug; 166(2):260-4. PubMed ID: 1321860
[TBL] [Abstract][Full Text] [Related]
15. Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs.
Hayward AR; Burger R; Scheper R; Arvin AM
J Virol; 1991 Mar; 65(3):1491-5. PubMed ID: 1847466
[TBL] [Abstract][Full Text] [Related]
16. Cellular interactions in the lysis of varicella-zoster virus infected human fibroblasts.
Hayward AR; Herberger M; Lazslo M
Clin Exp Immunol; 1986 Jan; 63(1):141-6. PubMed ID: 3485481
[TBL] [Abstract][Full Text] [Related]
17. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
[TBL] [Abstract][Full Text] [Related]
18. Human lymphocyte, monocyte and polymorphonuclear leucocyte mediated antibody-dependent cellular cytotoxicity against varicella-zoster virus-infected targets.
Ihara T; Ito M; Starr SE
Clin Exp Immunol; 1986 Jan; 63(1):179-87. PubMed ID: 3955882
[TBL] [Abstract][Full Text] [Related]
19. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
[TBL] [Abstract][Full Text] [Related]
20. Reduced cellular immunity to varicella zoster virus during treatment for acute lymphoblastic leukemia of childhood: in vitro studies of possible mechanisms.
Giller RH; Bowden RA; Levin MJ; Walker LJ; Tubergen DG; Hayward AR
J Clin Immunol; 1986 Nov; 6(6):472-80. PubMed ID: 3023433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
